- Home
- CTMX vs VEL Comparison
CTMX vs VEL Comparison
Compare CTMX & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTMX | VEL |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 677.2M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CTMX | VEL |
|---|---|---|
| Price | $4.44 | $17.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $11.90 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 9.4M | 111.9K |
| Earning Date | 03-16-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.98 |
| EPS | N/A | ★ 2.75 |
| Revenue | ★ $76,201,000.00 | N/A |
| Revenue This Year | N/A | $6.01 |
| Revenue Next Year | $27.22 | $19.02 |
| P/E Ratio | $22.58 | ★ $6.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $16.12 |
| 52 Week High | $8.21 | $21.40 |
Technical Indicators
Market Signals| Indicator | CTMX | VEL |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 41.93 |
| Support Level | $3.55 | $16.19 |
| Resistance Level | $6.20 | $19.38 |
| Average True Range (ATR) | 0.60 | 0.61 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 3.23 | 26.09 |
Price Performance
Historical ComparisonAbout CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.